MSF slams Bayer for saying drugs for those who can pay
NEW DELHI (AFP) - Global medical charity Medecins Sans Frontieres on Friday slammed a statement by Bayer's chief executive Marijn Dekkers that the giant German firm only developed its cancer drug Nexavar for people who could afford the medicine, not "for Indians".
India's controller general of patents angered Bayer in March 2012 when he authorised a local drugmaker to produce a generic copy of Nexavar, saying the German company charged a price that was too costly for most Indians.
"We did not develop this medicine (Nexavar) for Indians," Dr Dekkers said at a little reported pharmaceutical forum last month, according to the Jan 21 edition of Businessweek.
"We developed it for Western patients who can afford it," Dr Dekkers said, and called the Indian regulator's action "essentially theft".